Paraneoplastic neurologic disorders (PNDs) are cancer-related syndromes that can affect any part of the nervous system; caused by mechanisms other than metastasis or by complications of cancer such as coagulopathy, stroke, metabolic and nutritional conditions, infections, and side effects of cancer therapy. In 60% of pts the neurologic symptoms precede cancer diagnosis. PNDs occur in 0.5-1% of all cancer pts, but they occur in 2-3% of pts with neuroblastoma or small cell lung cancer (SCLC), and in 30-50% of pts with thymoma or sclerotic myeloma.